Ewha Womans University Seoul Hospital Introduces Re-Zoom Surgery...minimally invasive treatment with no side effects of prostatic hypertrophy
May 16, 2025
Mr. A, in his 50s, who was diagnosed with prostatic hypertrophy, considered surgery due to his lack of effectiveness during drug treatment, but hesitated because he was worried about side effects. After consideration, he visited the urology department of Ewha Womans University Seoul Hospital and received minimally invasive Rezum surgery after consulting with a specialist, and his condition improved.
According to Professor Ahn Hyun-kyu of the Department of Urology at Ewha Womans University Seoul Hospital, A has stopped administering all prostate hypertrophy drugs two months after the surgery because he has no discomfort in urination. All of the ejaculation disorders that appeared when administering prostate hypertrophy drugs have also recovered, and satisfaction is high not only in urination function but also in sex life.
Ewha Womans University Seoul Hospital preemptively introduced the re-zoom system in November last year and recorded about 50 procedures by May this year, making it the most active re-zoom surgery among domestic university hospitals.
Rezum surgery was approved by the U.S. FDA in 2015 as a treatment to reduce the size of the prostate by necrosis of prostate hypertrophic tissue using water vapor injection, and has been recognized as a new medical technology since January 2023.
Rezoom surgery, which has already been included in the guidelines of the American Society of Urology (AUA), has recently become one of the standard treatments for prostate hypertrophy as it can be performed quickly and safely with minimal invasion.
Professor Ahn Hyun-kyu, who conducted A's re-zoom surgery, explained, `Since it is important to minimize side effects such as retrograde ejaculation and sexual dysfunction as well as improvement of symptoms, patients with hyperprostate hypertrophy in their 50s and 60s often prefer re-zoom surgery in which a needle is inserted into the prostate without damaging any structures related to ejaculation at all.'
He then added that even patients in their 70s and 80s have very high satisfaction because bleeding can proceed simply and safely within 5 to 10 minutes under simple anesthesia.
Meanwhile, the Department of Urology at Ewha Womans University Seoul Hospital (Director Kim Kwang-hyun) is continuously introducing the latest technology to establish a patient-specific treatment system for increasing prostate hypertrophy.
In November 2022, the first university hospital in Korea introduced the Aquabim Robot System (AQUABEAM® Robotic System) and is continuously performing procedures. In addition, for giant prostate hypertrophy, single-hole robotic surgery (SP) has been applied for the first time in Korea, which is attracting attention as a new treatment option to complement traditional surgical methods such as transurethral prostatectomy (TURP) or HoLEP.
According to Professor Ahn Hyun-kyu of the Department of Urology at Ewha Womans University Seoul Hospital, A has stopped administering all prostate hypertrophy drugs two months after the surgery because he has no discomfort in urination. All of the ejaculation disorders that appeared when administering prostate hypertrophy drugs have also recovered, and satisfaction is high not only in urination function but also in sex life.
Ewha Womans University Seoul Hospital preemptively introduced the re-zoom system in November last year and recorded about 50 procedures by May this year, making it the most active re-zoom surgery among domestic university hospitals.
Rezum surgery was approved by the U.S. FDA in 2015 as a treatment to reduce the size of the prostate by necrosis of prostate hypertrophic tissue using water vapor injection, and has been recognized as a new medical technology since January 2023.
Rezoom surgery, which has already been included in the guidelines of the American Society of Urology (AUA), has recently become one of the standard treatments for prostate hypertrophy as it can be performed quickly and safely with minimal invasion.
Professor Ahn Hyun-kyu, who conducted A's re-zoom surgery, explained, `Since it is important to minimize side effects such as retrograde ejaculation and sexual dysfunction as well as improvement of symptoms, patients with hyperprostate hypertrophy in their 50s and 60s often prefer re-zoom surgery in which a needle is inserted into the prostate without damaging any structures related to ejaculation at all.'
He then added that even patients in their 70s and 80s have very high satisfaction because bleeding can proceed simply and safely within 5 to 10 minutes under simple anesthesia.
Meanwhile, the Department of Urology at Ewha Womans University Seoul Hospital (Director Kim Kwang-hyun) is continuously introducing the latest technology to establish a patient-specific treatment system for increasing prostate hypertrophy.
In November 2022, the first university hospital in Korea introduced the Aquabim Robot System (AQUABEAM® Robotic System) and is continuously performing procedures. In addition, for giant prostate hypertrophy, single-hole robotic surgery (SP) has been applied for the first time in Korea, which is attracting attention as a new treatment option to complement traditional surgical methods such as transurethral prostatectomy (TURP) or HoLEP.
|
This article was translated by Naver AI translator.
